Skip to content
FY'25FY'24FY'23FY'22
-$230.76M+11.1%-$259.62M-87.6%-$138.38M-128%$490.66M+4.6%
$23.56M+13.0%$20.85M+61.7%$12.9M+70.5%$7.57M+18.0%
$30.17M-38.9%$49.42M+42.9%$34.59M+85.3%$18.67M+78.5%
-$57.57M$126.22M-76.4%$535.98M+45.4%
$13.15M-55.7%$29.66M-54.8%$65.55M+284%$17.09M+15.1%
$0
-$31.41M-29.2%-$24.32M+80.1%-$122.31M+54.3%-$267.61M-340%
$5.44M-97.7%$234.39M+4,209%$5.44M-60.8%$13.9M+132%
-$16.5M+93.0%-$235.94M-$187.5M-17.9%
-$105.51M+60.0%-$264.04M-362%-$57.18M-171%$80.87M-74.3%
-$70.72M$518.89M+46.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Maravai LifeSciences Holdings, Inc. generate?
Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.